A pharmaceutical company expands its voluntary recall of two blood pressure medications after trace amounts of a potentially cancer-causing impurity were found during testing
The recall affects Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets.Tests of some of those medications revealed amounts of N-methylnitrosobutyric acid that were above the US Food and Drug Administration's daily acceptable levels.This recall is related to the valsartan recall that has been expanded multiple times since July, when separate lots of blood pressure medications from different companies began being pulled from pharmacy shelves.
Also known as ARBs, they block a potent chemical in the blood called angiotensin that causes muscles surrounding blood vessels to contract. When the chemical binds, it narrows the vessels, and that can cause high blood pressure.What this recall includesThis current expansion includes three additional lots of Losartan Potassium Tablets USP and two lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pittsburgh authorities identify 3 who died in suspected mass overdoseAuthorities identify 3 men who died in a suspected mass drug overdose at a Pittsburgh apartment complex that left 4 other men hospitalized.
Consulte Mais informação »